Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Simcha Therapeutics
Finance Watch: IPOs At A Standstill As US Biotech Stock Valuations Plummet
There have been no biopharma initial public offerings in the US since 12 January while the industry’s valuations have plummeted by double digits since the start of 2022. Nevertheless, venture capital investment continues at a fast pace and there have been some follow-on public offerings.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.